Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy (ALD) and/or adrenomyeloneuropathy (AMN)

AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy (ALD) and/or adrenomyeloneuropathy (AMN)

US Patent 11779655 · Granted Oct 10, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulf2024
Injection of single-stranded or self-complementary adeno-associated virus 9 into2024
Composition for treatment of Crigler-Najjar syndrome2024
Compositions comprising a lecithin cholesterol acyltransferase variant and uses 2024
AAV-mediated expression of anti-influenza antibodies and methods of use thereof2022
Compositions and methods useful for prophylaxis of organophosphates2022
Composition for treatment of Crigler-Najjar syndrome2022
Compositions for treatment of wet age-related macular degeneration2021
Compositions comprising AAV expressing dual antibody constructs and uses thereof2021
AAV mediated influenza vaccines2020
Compositions comprising AAV expressing dual antibody constructs and uses thereof2020
Tissue preferential codon modified expression cassettes, vectors containing same2020